109 related articles for article (PubMed ID: 7188625)
1. Cisplatin-induced hemolysis.
Getaz EP; Beckley S; Fitzpatrick J; Dozier A
N Engl J Med; 1980 Feb; 302(6):334-5. PubMed ID: 7188625
[No Abstract] [Full Text] [Related]
2. [The effect of platinum diamminodichloride (cis-platinum) in the treatment of metastasized testicular teratoma].
Stoter G; Vendrik CP; Struyvenberg A; Pinedo HM
Ned Tijdschr Geneeskd; 1978 Jul; 122(28):1015-20. PubMed ID: 353570
[No Abstract] [Full Text] [Related]
3. Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: a case report.
Mead GM; Green JA; Macbeth FR; Williams CJ; Whitehouse JM; Buchanan R
Cancer Treat Rep; 1983 Apr; 67(4):410. PubMed ID: 6189603
[No Abstract] [Full Text] [Related]
4. Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors.
Higby DJ; Wallace HJ; Albert DJ; Holland JF
Cancer; 1974 May; 33(5):1219-5. PubMed ID: 4856724
[No Abstract] [Full Text] [Related]
5. [Hemolytic anemias induced by drug hypersensitivity].
Weinreich J
Ther Ggw; 1969 Jun; 108(6):886-7 passim. PubMed ID: 5383170
[No Abstract] [Full Text] [Related]
6. Acute leukemia following cisplatin for bladder cancer.
Bassett WB; Weiss RB
J Clin Oncol; 1986 Apr; 4(4):614. PubMed ID: 3958773
[No Abstract] [Full Text] [Related]
7. Platin salts-induced hemolytic anemia: cisplatin- and the first case of carboplatin-induced hemolysis.
Maloisel F; Kurtz JE; Andres E; Gorodetsky C; Dufour P; Oberling F
Anticancer Drugs; 1995 Apr; 6(2):324-6. PubMed ID: 7795280
[TBL] [Abstract][Full Text] [Related]
8. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
Koch MO; Coussens D
Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
[No Abstract] [Full Text] [Related]
9. [Immunohematologic reactions during treatment with penicillin].
Spath P; Garratty G; Petz LD
Schweiz Med Wochenschr; 1973 Mar; 103(10):383-8 contd. PubMed ID: 4692063
[No Abstract] [Full Text] [Related]
10. Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder.
Keating JP; Zincke H; Hahn RG; Morgan WR
Prog Clin Biol Res; 1990; 353():119-27. PubMed ID: 2217409
[No Abstract] [Full Text] [Related]
11. Assessment of quality of life in long-term survivors treated by first-line intravenous cisplatin for invasive bladder cancer.
Raghavan D; Grundy R; Lancaster L
Prog Clin Biol Res; 1988; 260():625-31. PubMed ID: 3362911
[No Abstract] [Full Text] [Related]
12. [Cis-platinum in the treatment of disseminated testicular neoplasms resistant to classical chemotherapy].
Kuss R; Khoury S; Richard F; Fourcade R; Frantz P; Capelle JP
J Urol Nephrol (Paris); 1978; 84(10-11):741-7. PubMed ID: 745255
[TBL] [Abstract][Full Text] [Related]
13. [cis-Diamino-dichloro-platinum (II) in the treatment of otherwise treatment-resistant malignant testicular teratoma (author's transl)].
Osieka R; Bruntsch U; Gallmeier WM; Seeber S; Schmidt CG
Dtsch Med Wochenschr; 1976 Feb; 101(6):191-5, 199. PubMed ID: 1248396
[TBL] [Abstract][Full Text] [Related]
14. Chlorpropamide-induced immune hemolytic anemia.
Logue GL; Boyd AE; Rosse WF
N Engl J Med; 1970 Oct; 283(17):900-4. PubMed ID: 5458054
[No Abstract] [Full Text] [Related]
15. Induction chemotherapy with cisplatin and cyclophosphamide and maintenance chemotherapy with doxorubicin and 5-FU in advanced urinary bladder tumors.
Sulkes A; Fuks Z
Cancer Treat Rep; 1983 Feb; 67(2):200-1. PubMed ID: 6681734
[No Abstract] [Full Text] [Related]
16. [Aggressive preoperative chemotherapy in infiltrating bladder carcinoma with a combination of cisplatin, cyclophosphamide and adriamycin. Preliminary report].
Martínez-Piñeiro JA; de la Peña JJ; Hidalgo L; Cisneros J; Jiménez de León J; Machuca J
Arch Esp Urol; 1986; 39(1):33-46. PubMed ID: 3707210
[No Abstract] [Full Text] [Related]
17. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder.
Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW
J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of cisplatin-resistant human testicular and bladder tumour cell lines.
Walker MC; Povey S; Parrington JM; Riddle PN; Knuechel R; Masters JR
Eur J Cancer; 1990; 26(6):742-7. PubMed ID: 2144165
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers].
Takenaka A; Gotoh A; Hara I; Gohji K; Ogawa T; Arakawa S; Matsumoto O; Kamidono S; Hamami G; Itani A
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1909-15. PubMed ID: 2393308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
